Viewing Study NCT06711705


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2025-12-26 @ 2:13 AM
Study NCT ID: NCT06711705
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2024-11-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Elranatamab in Relapsed/Refractory Multiple Myeloma
Sponsor: University of California, San Diego
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module